The document discusses guidelines for using amplitude integrated EEG (aEEG) or cerebral function monitoring (CFM) to assess brain activity in newborns experiencing hypoxic-ischemic encephalopathy (HIE) or other neurological conditions. CFM can help predict outcomes from HIE by identifying abnormal brain activity in the first 6 hours after birth and detecting neonatal seizures. The document provides guidance on proper electrode placement and interpreting CFM readings to distinguish normal and abnormal brain activity patterns while avoiding common artifacts.